Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 2/29/2024 | 8/31/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Market Cap | £13,012 | £15,941 | £17,201 | £24,616 |
| - Cash | £846 | £911 | £3,209 | £780 |
| + Debt | £5,122 | £5,262 | £5,301 | £10,424 |
| Enterprise Value | £17,288 | £20,292 | £19,293 | £34,260 |
| Revenue | £1,553 | £1,186 | £28 | £1,124 |
| % Growth | 30.9% | 4,135.7% | -97.5% | – |
| Gross Profit | £775 | £456 | £28 | £344 |
| % Margin | 49.9% | 38.4% | 100% | 30.6% |
| EBITDA | -£2,342 | -£604 | -£736 | -£2,693 |
| % Margin | -150.8% | -50.9% | -2,628.6% | -239.6% |
| Net Income | -£2,529 | -£1,099 | £8,160 | -£4,056 |
| % Margin | -162.8% | -92.7% | 29,142.9% | -360.9% |
| EPS Diluted | -0.034 | -0.015 | 0.11 | -0.058 |
| % Growth | -130.4% | -113.5% | 289.7% | – |
| Operating Cash Flow | -£1,201 | -£2,180 | -£3,946 | -£2,845 |
| Capital Expenditures | -£5 | -£4 | -£6 | -£25 |
| Free Cash Flow | -£1,206 | -£2,184 | -£3,952 | -£2,870 |